Skip to main content
Top
Published in: Diabetes Therapy 5/2018

Open Access 01-10-2018 | Review

A Systematic Review of Ultrasound-Detected Lipohypertrophy in Insulin-Exposed People with Diabetes

Authors: Haya Abu Ghazaleh, Rabab Hashem, Angus Forbes, Thandiwe Rebecca Dilwayo, Maria Duaso, Jackie Sturt, Susan Halson-Brown, Henrietta Mulnier

Published in: Diabetes Therapy | Issue 5/2018

Login to get access

Abstract

Introduction

Lipohypertrophy (LH) is a common complication occurring in diabetes individuals. The most common methods used include palpation, visual examination and/or ultrasound (US). To date, there is limited information on the detection sensitivity among the different techniques used to identify LH. This systematic review aimed to identify studies that examined insulin-related LH using US detection to identify the prevalence, characteristics and morphology of LH, and to compare US and clinical palpation methods for detecting LH.

Methods

Three electronic databases were systematically searched for studies detecting LH using US in insulin users. Articles were screened for eligibility and included studies were appraised using quality assessment tools. The quality of the evidence was evaluated using Grading of Recommendations Assessment, Development and Evaluation, and the extracted data was synthesised narratively.

Results

Sixteen articles were included in the review providing data on 1722 patients. The prevalence of LH prevalence varied from 14.5% to 88% (median 56.6%). Identified risk factors for the development of included insulin injection behaviour such as a lack of injection site rotation and social factors such as low education level. Four studies compared LH detection by US to palpation, providing inconsistent results. One study showed that palpation detected 64% more LH, whilst two studies demonstrated that US identified 50% more sites and extended areas of LH (additional ~ 5 cm2). Another study provided comparable estimates between palpation and US in clinicians trained to detect LH (97%).

Conclusion

The evidence highlights a lack of congruence in results pertaining to the detection sensitivity of US and palpation for LH sites. More research with robust study design is needed to verify whether clinically palpation is sufficient to detect LH, or whether US would increase the precision of LH assessment to help address this common clinically significant problem.
Appendix
Available only for authorised users
Literature
1.
go back to reference Hauner H, Stockamp B, Haastert B. Prevalence of lipohypertrophy in insulin-treated diabetic patients and predisposing factors. Exp Clin Endocrinol Diabetes. 1996;104(2):106–10.CrossRefPubMed Hauner H, Stockamp B, Haastert B. Prevalence of lipohypertrophy in insulin-treated diabetic patients and predisposing factors. Exp Clin Endocrinol Diabetes. 1996;104(2):106–10.CrossRefPubMed
2.
go back to reference Richardson T, Kerr D. Skin-related complications of insulin therapy: epidemiology and emerging management strategies. Am J Clin Dermatol. 2003;4(10):661–7.CrossRefPubMed Richardson T, Kerr D. Skin-related complications of insulin therapy: epidemiology and emerging management strategies. Am J Clin Dermatol. 2003;4(10):661–7.CrossRefPubMed
3.
go back to reference Al Hayek AA, et al. Frequency of lipohypertrophy and associated risk factors in young patients with type 1 diabetes: a cross-sectional study. Diabetes Ther. 2016;7(2):259–67.CrossRefPubMedPubMedCentral Al Hayek AA, et al. Frequency of lipohypertrophy and associated risk factors in young patients with type 1 diabetes: a cross-sectional study. Diabetes Ther. 2016;7(2):259–67.CrossRefPubMedPubMedCentral
4.
go back to reference Famulla S, et al. Insulin injection into lipohypertrophic tissue: blunted and more variable insulin absorption and action and impaired postprandial glucose control. Diabetes Care. 2016;39(9):1486–92.CrossRefPubMed Famulla S, et al. Insulin injection into lipohypertrophic tissue: blunted and more variable insulin absorption and action and impaired postprandial glucose control. Diabetes Care. 2016;39(9):1486–92.CrossRefPubMed
5.
go back to reference Gentile S, et al. Skin complications of insulin injections: a case presentation and a possible explanation of hypoglycaemia. Diabetes Res Clin Pract. 2018;138:284–7.CrossRefPubMed Gentile S, et al. Skin complications of insulin injections: a case presentation and a possible explanation of hypoglycaemia. Diabetes Res Clin Pract. 2018;138:284–7.CrossRefPubMed
6.
go back to reference Johansson U-B, et al. Impaired absorption of insulin aspart from lipohypertrophic injection sites. Diabetes Care. 2005;28(8):2025–7.CrossRefPubMed Johansson U-B, et al. Impaired absorption of insulin aspart from lipohypertrophic injection sites. Diabetes Care. 2005;28(8):2025–7.CrossRefPubMed
7.
go back to reference De Coninck C, et al. Results and analysis of the 2008–2009 Insulin Injection Technique Questionnaire survey. J Diabetes. 2010;2(3):168–79.CrossRefPubMed De Coninck C, et al. Results and analysis of the 2008–2009 Insulin Injection Technique Questionnaire survey. J Diabetes. 2010;2(3):168–79.CrossRefPubMed
8.
go back to reference Vardar B, Kızılcı S. Incidence of lipohypertrophy in diabetic patients and a study of influencing factors. Diabetes Res Clin Pract. 2007;77(2):231–6.CrossRefPubMed Vardar B, Kızılcı S. Incidence of lipohypertrophy in diabetic patients and a study of influencing factors. Diabetes Res Clin Pract. 2007;77(2):231–6.CrossRefPubMed
9.
go back to reference Gentile S, et al. Factors hindering correct identification of unapparent lipohypertrophy. J Diabetes Metab Disord Control. 2016;3(2):00065. Gentile S, et al. Factors hindering correct identification of unapparent lipohypertrophy. J Diabetes Metab Disord Control. 2016;3(2):00065.
10.
go back to reference Partanen TM, Rissanen A. Insulin injection practices. Pract Diabetes. 2000;17(8):252–4.CrossRef Partanen TM, Rissanen A. Insulin injection practices. Pract Diabetes. 2000;17(8):252–4.CrossRef
11.
go back to reference Frid A, et al. New injection recommendations for patients with diabetes. Diabetes Metab. 2010;36:S3–18.CrossRefPubMed Frid A, et al. New injection recommendations for patients with diabetes. Diabetes Metab. 2010;36:S3–18.CrossRefPubMed
12.
13.
go back to reference Smith M, Clapham L, Strauss K. UK lipohypertrophy interventional study. Diabetes Res Clin Pract. 2017;126:248–53.CrossRefPubMed Smith M, Clapham L, Strauss K. UK lipohypertrophy interventional study. Diabetes Res Clin Pract. 2017;126:248–53.CrossRefPubMed
14.
go back to reference Gentile S, et al. A suitable palpation technique allows to identify skin lipohypertrophic lesions in insulin-treated people with diabetes. SpringerPlus. 2016;5(1):1–7.CrossRef Gentile S, et al. A suitable palpation technique allows to identify skin lipohypertrophic lesions in insulin-treated people with diabetes. SpringerPlus. 2016;5(1):1–7.CrossRef
19.
go back to reference Bertuzzi F, et al. Ultrasound characterization of insulin induced lipohypertrophy in type 1 diabetes mellitus. J Endocrinol Investig. 2017;2017:1–7. Bertuzzi F, et al. Ultrasound characterization of insulin induced lipohypertrophy in type 1 diabetes mellitus. J Endocrinol Investig. 2017;2017:1–7.
20.
go back to reference Blanco M, et al. Prevalence and risk factors of lipohypertrophy in insulin-injecting patients with diabetes. Diabetes Metab. 2013;39(5):445–53.CrossRefPubMed Blanco M, et al. Prevalence and risk factors of lipohypertrophy in insulin-injecting patients with diabetes. Diabetes Metab. 2013;39(5):445–53.CrossRefPubMed
21.
go back to reference Conwell LS, et al. Dermatological complications of continuous subcutaneous insulin infusion in children and adolescents. J Pediatr. 2008;152(5):622–8.CrossRefPubMed Conwell LS, et al. Dermatological complications of continuous subcutaneous insulin infusion in children and adolescents. J Pediatr. 2008;152(5):622–8.CrossRefPubMed
22.
go back to reference Davidenko I, Volkova N, Rudakova J. Estimation risk model of insulin induced lipohypertrophy in diabetic patients. Diabetes Technol Ther. 2014;16:A125.CrossRef Davidenko I, Volkova N, Rudakova J. Estimation risk model of insulin induced lipohypertrophy in diabetic patients. Diabetes Technol Ther. 2014;16:A125.CrossRef
23.
go back to reference Kasperska-Czyzyk T, Stefanski P, Elwertowski M. Ultrasonographic assessment of subcutaneous lipohypertrophy at insulin injection sites. Diabetes Res Clin Pract. 2000;50:78.CrossRef Kasperska-Czyzyk T, Stefanski P, Elwertowski M. Ultrasonographic assessment of subcutaneous lipohypertrophy at insulin injection sites. Diabetes Res Clin Pract. 2000;50:78.CrossRef
24.
go back to reference Mulnier H, et al. Subcutaneous tissue changes and dermal inflammation at insulin injections sites: a feasibility study using ultrasound to describe characterise and grade lipohypertrophy. Diabetologia. 2017;60(1 Suppl 1):S90. Mulnier H, et al. Subcutaneous tissue changes and dermal inflammation at insulin injections sites: a feasibility study using ultrasound to describe characterise and grade lipohypertrophy. Diabetologia. 2017;60(1 Suppl 1):S90.
25.
go back to reference Nasser J, Hammad F, Omran A. Lipohypertrophy among insulin-treated patients. Bahrain Med Bull. 2017;39(3):146–9.CrossRef Nasser J, Hammad F, Omran A. Lipohypertrophy among insulin-treated patients. Bahrain Med Bull. 2017;39(3):146–9.CrossRef
26.
go back to reference Patrakeeva E, et al. Post-injection lipohypertrophy in T1DM patients using continuous insulin infusion (CSII) and multiple daily injections (MDI). Diabetes Technol Ther. 2014;16:A154–5. Patrakeeva E, et al. Post-injection lipohypertrophy in T1DM patients using continuous insulin infusion (CSII) and multiple daily injections (MDI). Diabetes Technol Ther. 2014;16:A154–5.
27.
go back to reference Perciun R. Ultrasonographic aspect of subcutaneous tissue dystrophies as a result of insulin injections. Med Ultrasonogr. 2010;12(2):104–9. Perciun R. Ultrasonographic aspect of subcutaneous tissue dystrophies as a result of insulin injections. Med Ultrasonogr. 2010;12(2):104–9.
28.
go back to reference Perciun R, Mihu M. The subcutis ultrasound map of type 1 diabetic children improves the diagnosis of local dystrophies and insulin injection technique. Pediatr Res Int J. 2014;2014(10):402780. Perciun R, Mihu M. The subcutis ultrasound map of type 1 diabetic children improves the diagnosis of local dystrophies and insulin injection technique. Pediatr Res Int J. 2014;2014(10):402780.
29.
go back to reference Volkova N, et al. Ultrasonography of insulin injection sites in diabetic patients: a new method of lipohypertrophy diagnostics. Endocrine reviews. Conference: 95th annual meeting and expo of the Endocrine Society, ENDO, 2013. 34(3 Suppl. 1). Volkova N, et al. Ultrasonography of insulin injection sites in diabetic patients: a new method of lipohypertrophy diagnostics. Endocrine reviews. Conference: 95th annual meeting and expo of the Endocrine Society, ENDO, 2013. 34(3 Suppl. 1).
30.
go back to reference Wang W, Guo X, Shen G. Skin and subcutaneous layer thickness and prevalence of lipodystrophy at sites used for insulin injections in Chinese diabetic patients. Diabetes. 2014;63:A603. Wang W, Guo X, Shen G. Skin and subcutaneous layer thickness and prevalence of lipodystrophy at sites used for insulin injections in Chinese diabetic patients. Diabetes. 2014;63:A603.
31.
go back to reference Seyoum B, Abdulkadir J. Systematic inspection of insulin injection sites for local complications related to incorrect injection technique. Trop Doct. 1996;26(4):159–61.CrossRefPubMed Seyoum B, Abdulkadir J. Systematic inspection of insulin injection sites for local complications related to incorrect injection technique. Trop Doct. 1996;26(4):159–61.CrossRefPubMed
32.
go back to reference Perciun R, Telcian A, Olariu L. Ultrasound assessment of cutaneous/subcutaneous dystrophies in insulin-treated patients. A report on two cases. Med Ultrasonogr. 2012;14(1):60–3. Perciun R, Telcian A, Olariu L. Ultrasound assessment of cutaneous/subcutaneous dystrophies in insulin-treated patients. A report on two cases. Med Ultrasonogr. 2012;14(1):60–3.
33.
go back to reference Kapeluto J, et al. Criteria for the detection of insulin-induced lipohypertrophy using ultrasonography. Can J Diabetes. 2015;39(6):534.CrossRef Kapeluto J, et al. Criteria for the detection of insulin-induced lipohypertrophy using ultrasonography. Can J Diabetes. 2015;39(6):534.CrossRef
34.
go back to reference FIT UK. The First UK Injection Technique Recommendations, in The Forum for Injection Technique (FIT). 2010. FIT UK. The First UK Injection Technique Recommendations, in The Forum for Injection Technique (FIT). 2010.
Metadata
Title
A Systematic Review of Ultrasound-Detected Lipohypertrophy in Insulin-Exposed People with Diabetes
Authors
Haya Abu Ghazaleh
Rabab Hashem
Angus Forbes
Thandiwe Rebecca Dilwayo
Maria Duaso
Jackie Sturt
Susan Halson-Brown
Henrietta Mulnier
Publication date
01-10-2018
Publisher
Springer Healthcare
Published in
Diabetes Therapy / Issue 5/2018
Print ISSN: 1869-6953
Electronic ISSN: 1869-6961
DOI
https://doi.org/10.1007/s13300-018-0472-7

Other articles of this Issue 5/2018

Diabetes Therapy 5/2018 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.